Tiazofurin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTiazofurin
Drug Alias Name噻唑羧胺核苷TiazofurinumTiazofurine噻唑呋林Tiazofurina +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInosine-5'-monophosphate dehydrogenase (IMPDH) inhibitorsImmunomodulators
TargetsInosine-5'-monophosphate dehydrogenase (IMPDH)
Therapy Area/IndicationsOvarian NeoplasmsMultiple MyelomaLeukemia, Myelogenous, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBausch Health Companies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBausch Health Companies Inc
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsMultiple MyelomaLeukemia, Myelogenous, Chronic

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG